SYN : Analysis & Opinions

  1. Synthetic Biologics Commences Phase Ib Study on SYN-004 - Analyst ...

    December 31, 2014
    Synthetic Biologics, Inc. (SYN) announced the commencement and dosing of the first patient in a phase Ib study on its oral ...
  2. Synthetic Biologics Unveils Top-Line Safety Data on SYN-004 - ...

    December 29, 2014
    Synthetic Biologics, Inc. (SYN) announced positive results from the first safety and tolerability review in a phase Ia study ...
  3. Syngenta's Growth Strategy

    July 14, 2011
    Seed-maker Syngenta merged its two major divisions in an effort to boost growth. The market is not yet sure how well this ...
Trading Center